3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Neoplasms
4
Stomatitis
3
Neoplasm Metastasis
2
Head and Neck Neoplasms
2
Cancer Pain
2
Thromboembolism
1
Successful Conversion Rate of Operation
1
Sarcoma
1
Respiratory Insufficiency
1
Prostatic Neoplasms
1
Pneumonia
1
Pancreatic Neoplasms
1
Pain
1
Myocardial Infarction
1
Multiple Myeloma
1
Mucositis
1
Lymphoma
1
Lung Neoplasms
1
Leukemia, Myeloid, Acute
1
Kidney Diseases
1
Hematologic Neoplasms
1
Arrhythmias, Cardiac
1
Angina, Unstable
1
Adenocarcinoma
1
Acute Coronary Syndrome
1
Interventions
Docetaxel
171
Radiotherapy
144
Magnetic Resonance Spectroscopy
142
Leuprolide
112
Prednisone
108
enzalutamide
102
Radiosurgery
101
Abiraterone Acetate
94
Androgen Antagonists
91
Goserelin
83
bicalutamide
81
gallium 68 PSMA-11
70
Surveys and Questionnaires
63
apalutamide
57
Specimen Handling
56
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
55
Radiation
47
Gonadotropin-Releasing Hormone
45
Standard of Care
44
Biopsy
44
Brachytherapy
42
Radiotherapy, Intensity-Modulated
40
Blood Specimen Collection
40
darolutamide
39
abiraterone
39
cabazitaxel
35
Exercise
35
Carboplatin
33
Pluvicto
32
Triptorelin Pamoate
31
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Prostatic Neoplasms
×
Sodium Bicarbonate
×
Clear all
NCT06661902
2026-02-17
BURN
University of Washington
Phase 1/2
Completed
350 enrolled